New Era in Atopic Dermatitis Treatment: Results of Long-Term Dupilumab Administration
Atopic dermatitis (AD) is a disease characterized by chronic skin inflammation and epidermal barrier dysfunction leading to decrease in patients' quality of life. AD is widespread in general population including children. This article covers the disease pathophysiological mechanisms including t...
Main Authors: | Nikolay N. Murashkin, Leonid A. Opryatin, Roman V. Epishev, Alexander I. Materikin, Eduard T. Ambarchyan, Roman A. Ivanov, Dmitriy V. Fedorov, Daria S. Kukoleva |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2021-11-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/2757 |
Similar Items
-
Biologic Therapy of Moderate and Severe Forms of Atopic Dermatitis in Children
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01) -
Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in Children
by: Nikolay N. Murashkin, et al.
Published: (2016-12-01) -
Climatic Effect on Atopic Dermatitis Course and Therapeutic Capabilities
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01) -
Mechanisms of Development and Variants of Therapeutic Management of Steroid Resistance in Patients with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01) -
Influence of dupilumab on the economic burden of severe asthma and atopic dermatitis
by: I. S. Krysanov, et al.
Published: (2020-09-01)